JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cànaves, J. M.
Right arrow Articles by Montal, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cànaves, J. M.
Right arrow Articles by Montal, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 51, 34214-34221, December 18, 1998


Assembly of a Ternary Complex by the Predicted Minimal Coiled-coil-forming Domains of Syntaxin, SNAP-25, and Synaptobrevin
A CIRCULAR DICHROISM STUDY*

Jaume M. Cànaves and Mauricio MontalDagger

From the Department of Biology, University of California San Diego, La Jolla, California 92093-0366

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

The assembly of target (t-SNARE) and vesicle-associated SNAP receptor (v-SNARE) proteins is a critical step for the docking of synaptic vesicles to the plasma membrane. Syntaxin-1A, SNAP-25, and synaptobrevin-2 (also known as vesicle-associated membrane protein, or VAMP-2) bind to each other with high affinity, and their binding regions are predicted to form a trimeric coiled-coil. Here, we have designed three peptides, which correspond to sequences located in the syntaxin-1A H3 domain, the C-terminal domain of SNAP-25, and a conserved central domain of synaptobrevin-2, that exhibit a high propensity to form a minimal trimeric coiled-coil. The peptides were synthesized by solid phase methods, and their interactions were studied by CD spectroscopy. In aqueous solution, the peptides were unstructured and showed no interactions with each other. In contrast, upon the addition of moderate amounts of trifluoroethanol (30%), the peptides adopted an alpha -helical structure and displayed both homomeric and heteromeric interactions. The interactions observed in ternary mixtures induce a stabilization of peptide structure that is greater than that predicted from individual binary interactions, suggesting the formation of a higher order structure compatible with the assembly of a trimeric coiled-coil.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

The assembly of the synaptic core complex is essential for Ca2+-dependent neuroexocytosis. This early event in the secretory cascade is then followed by the priming and vesicle fusion steps (1-6). According to the SNARE1 model, docking of synaptic vesicles to the plasma membrane is a critical step that involves the formation of a ternary complex by the v-SNARE synaptobrevin (also known as vesicle-associated membrane protein, or VAMP), and two t-SNAREs: SNAP-25 and syntaxin (7-9). Reconstitution of the v-SNARE synaptobrevin into lipid vesicles and the two t-SNAREs, SNAP-25 and syntaxin, into a distinct vesicle pool has provided evidence that the formation of a ternary complex is sufficient to join the independent vesicle pools and lead to fusion of the apposed bilayer membranes (10).

Understanding the interactions between the proteins of the trimeric complex in a simplified model may outline new ways to control its assembly and dissociation or to modulate the conformational changes that are presumably necessary for the progression from the docking step to the subsequent phases in the secretory process. The structural domains that appear to be implicated in the protein-protein interactions between SNAP-25, synaptobrevin, and syntaxin show a high propensity for the formation of alpha -helices (11-15). Secondary structure analysis shows that the periodic distribution of hydrophobic amino acids is consistent with a coiled-coil organization (2, 11, 12, 14, 15). Fluorescence energy transfer experiments (12) and electron microscopy (15) further indicate that synaptobrevin and syntaxin are aligned in parallel in the context of a ternary coiled-coil.

To investigate the postulated coiled-coil interactions between the proteins that constitute the docking complex in a minimal model, we have applied the principles involved in the formation of stable coiled-coils (16) to design three peptides corresponding to predicted coiled-coil-forming domains in SNAP-25, synaptobrevin-2, and syntaxin-1A. We have used CD spectroscopy to determine the secondary structure of these peptides and their interactions in binary and tertiary mixtures. Our findings are consistent with the assembly of the predicted ternary complex.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Reagents-- HPLC grade trifluoroacetic acid, trifluoroethanol (TFE), ethanedithiol, thioanisol, phenol, and acetonitrile were purchased from Aldrich. Methyl tert-butyl ether was from Fisher. HPLC columns were from Vydac (Hesperia, CA). L-Amino acids and protected derivatives used for peptide synthesis were made by Calbiochem. Benzoic anhydride was obtained from Sigma. All other reagents for peptide synthesis and resins were from Applied Biosystems (Foster City, CA).

Peptide Synthesis and Purification-- Peptides SN (human brain SNAP-25-(181-206)), SB (human brain synaptobrevin-2-(40-67)), ST (human brain syntaxin-1A-(191-218)), and SNRD (scrambled SN peptide sequence: ESDNDTRAIKITQAGSMKRMGLNAKE) were produced using solid phase peptide synthesis. Synthesis started with a p-hydroxymethyl phenoxy methyl polysterene resin and was carried out using the Fastmoc® Fmoc strategy on an Applied Biosystems peptide synthesizer model 431A (Foster City, CA) according to a single coupling plus capping protocol. Cleavage from the resin and removal of all protecting groups was accomplished by using trifluoroacetic acid cleavage as described (17). Crude peptides were precipitated from the trifluoroacetic acid mixture in cold methyl tert-butyl ether and centrifuged, the supernatant was discarded, and the remaining methyl tert-butyl ether was removed under high vacuum at 0 °C for 3 h. Samples of crude peptide (10-20 mg) were dissolved in 0.1% trifluoroacetic acid, applied to a semipreparatory column (Vydac, C-18), and eluted at a flow rate of 3 ml/min with a linear gradient of 90% acetonitrile in 0.1% trifluoroacetic acid. Eluted peaks were monitored by absorbance measurements at 214 nm, pooled, and lyophilized. Peptide purity was assessed by RP-HPLC in an analytical column (Vydac, C-18).

Secondary and Tertiary Structure Predictions-- Propensities of peptides to adopt a coiled-coil structure were estimated using two different programs: Coils and Paircoil. The Coils program uses the Lupas algorithm (18, 19). Sequences were compared with an unweighted MTIDK matrix (18) using 14- and 28-residue scanning windows. The second program uses the Berger algorithm (20), which is more stringent. Both methods are based on the relative frequency of occurrence of amino acids at each position (a-g) of the coiled-coil heptad repeat. Secondary structure predictions were performed using the SOPMA method (21, 22) and the AGADIR program (23).

CD Measurements-- CD measurements were carried out on a modified Cary 61 (24) or an AVIV model 202 spectropolarimeter. The original Pockel cell and Cary linear polarizer in the Cary 61 were replaced with a 50-kHz photoelastic modulator (Hinds International, FS-5/PEM-80) and a MgF2 linear polarizer (AVIV Inc.). The phase-detected output of the original end-on photomultiplier and preamplifier were integrated using an Egg Princeton Applied Research model 128A lock-in amplifier. System automation and multiple scan averaging were accomplished with an IBM PC-compatible computer interfaced directly to both the Cary 61 and the 128A amplifier. Constant N2 flushing was employed. Spectra were measured at 195-250 nm using a 0.05-cm cell, a 1-nm bandwidth, a 0.3-ms time constant, and a cell temperature of 25 °C. All recordings were performed in 10 mM sodium phosphate buffer, pH 7.4, 100 mM NaCl, with or without TFE, unless otherwise indicated. Twenty scans were averaged for every spectrum. Base line subtraction, conversion of measured rotations to mean residue ellipticity [theta ] (deg·cm2·dmol-1) (25), and filtering of the spectra using a fast fourier transform filter were performed using the Microcal Origin 3.5 program. The percentage of alpha -helical content was estimated directly from the molar residue ellipticity at 222 nm as described by Chen et al. (26). Percentages of secondary structures were also estimated using the neural network-based K2 algorithm (27). To evaluate the spectral changes induced by peptide-peptide interactions in mixtures, the noninteracting spectra were calculated from the individual spectra using the equation,
[&thgr;]<SUB><UP>theo</UP></SUB>=∑(c<SUB>i</SUB> · n<SUB>i</SUB> · [&thgr;]<SUB>i</SUB>)/∑(c<SUB>i</SUB> · n<SUB>i</SUB>) (Eq. 1)
where ci denotes the molar peptide concentrations, ni represents the peptide lengths in number of residues, and [theta ]i values are observed mean residue ellipticities.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Peptide Design

Basic Criteria for the Design of the Minimal Predicted Coiled-coil-forming Peptides-- The sequences of the peptides synthesized from selected regions from human SNAP-25 (peptide SN), synaptobrevin-2 (peptide SB), and syntaxin-1A (peptide ST) are shown in Fig. 1A. Sequence selection was based on six criteria: 1) information about the minimal domains of SNAP-25, synaptobrevin, and syntaxin involved in protein-protein interactions in the core complex (1-5, 28); 2) botulinum neurotoxins (BoNTs) cleavage sites and their effects on neurotransmitter release (29-37); 3) sequence specificity of peptides inhibitors of neurotransmitter release (38-44); 4) effects of point mutations on the process of secretion and endocytosis (4, 11, 44-47); 5) predictions of secondary structure formation of coiled-coil structures; and 6) a minimum length for a stable parallel coil peptide of ~28 residues, or 4 heptad repeats (48, 49).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Model of a minimal trimeric coiled-coil using selected sequences from SNAP-25, synaptobrevin-2, and syntaxin-A. A, schematic representation of the relative location of SNAP-25, synaptobrevin-2, and syntaxin-A in the synaptic terminal (black boxes). The white boxes represent the segments corresponding to the synthetic peptides SN, SB, and ST, respectively. The relative size of the proteins and synthetic peptides are not to scale. The amino acid sequences of the SN, SB, and ST peptides are given in the box. B, triple helical coiled-coil model of the segments of SNAP-25, synaptobrevin-2, and syntaxin-A represented by the synthetic peptides SN, SB, and ST, respectively. The sequences have a heptad pattern of residues (designated as a-g), where a and d are usually hydrophobic and e and g are frequently charged. Solid arrows denote hydrophobic interactions in the core of the complex, whereas broken arrows refer to potential ionic interactions, as described in detail in C. Mutations known to disrupt the interactions between proteins (*) are located in the hydrophobic core. Mutations known not to interfere in the assembly of the complex (#) are all located outside the hydrophobic core. Most of the charged residues are located in the outer shell of the complex (positions b, c, and f). Hollow arrows in A and B show the relative location of Botulinum neurotoxin cleavage sites, which are all accessible on the surface of the complex. C, potential interactions between charged residues of peptides SN, SB, and ST. Charged residues in positions e and g or at i + 3- or i + 4-positions can form intramolecular (squares) or intermolecular (circles) salt bridges that contribute to the overall stability of the trimeric complex.

Design of the SN Peptide-- The region of SNAP-25 interacting with synaptobrevin-2 has been localized between residue 41 and the C-terminal residue (2, 4). The segment from residue 181 to the C terminus is necessary for the SNAP-25-synaptobrevin interaction (3). Peptides corresponding to the 20 and 26 C-terminal residues, the latter analogous to the SNAP-25 segment released after cleavage by BoNT E, inhibit neurotransmitter release with IC50 values of 10 and 0.25 µM, presumably by preventing the docking of synaptic vesicles (40, 43).

The C-terminal region of SNAP-25 delimited by residues 169 and 206 displays a high propensity (99%) to form coiled-coil structures. Two distinct domains are predicted: one from position 166 to 187 (62%), and the second from position 189 to the C terminus (55%). Accordingly, the 26-residue peptide corresponding to the C-terminal segment of SNAP-25, hereafter designated as SN, was selected based on the fact that it is nearly 4 heptads long, it exhibits high propensity to form coiled-coils, and it is an efficient inhibitor of neurotransmitter release (Fig. 1A, Peptide SN).

Design of the ST Peptide-- Similar considerations were used in the design of a potentially coiled-coil-forming peptide from syntaxin-1A. The region between positions 194 and 261 is necessary for the interaction with synaptobrevin-2 and SNAP-25 (2, 3, 5). The segment necessary for interaction with SNAP-25 has been located between residues 199 and 267 (1) and further delimited to residues 199-220 (4). All of these studies confine the SNAP-25 binding region on syntaxin to the N-terminal portion of the H3 domain (residues 191-266) (2, 4), and a putative minimal SNAP-25 binding domain (residues 189-220) has been identified (11, 44). Coiled-coil predictions using the sequence of human syntaxin revealed a region between positions 199 and 214 with high probability (78%) of coiled-coil formation.

Syntaxin-1A mutants containing point mutations (4, 11, 44) at the a and d repeats of a predicted coiled-coil show reduced SNAP-25 binding, supporting the involvement of this region in the interaction with SNAP-25 (Fig. 1B). Peptides corresponding to the predicted coiled-coil-forming region of syntaxin-1A have also been shown to inhibit neurotransmitter release (11, 42, 44). Given these considerations, the selected 4-heptad synthetic peptide corresponding to human syntaxin spanned from residue 191 to 218 (Fig. 1A, Peptide ST).

Design of the SB Peptide-- The region of synaptobrevin-2 between positions 27 and 96 interacts with both SNAP-25 and syntaxin-1A in the core complex (3, 28). Synaptobrevin-2 contains a conserved domain between residues 57 and 88, with high propensity (95%) to form coiled-coils, and two distinct subdomains (28-42 and 52-72). Deletion of the region spanning from residue 41 to 50 abolishes endocytosis (45), and mutants lacking the segments 41-50 or 51-60 do not to bind to SNAP-25 and syntaxin-1A. The mutants with deletion of segment 31-38 show weak binding to t-SNAREs, whereas the deletion of segments 61-70 or 71-80 results in poor binding to syntaxin while maintaining the interactions with SNAP-25 (47). Moreover, a single mutation (M46A) inhibits endocytosis by 80% and reduces binding to syntaxin-1A and SNAP-25 (45, 46). Taken together, this information suggests that the region delimited by positions 40 and 60 is involved in the ternary interactions that result in the assembly of the docking complex; therefore, the peptide synthesized encompassed 4 heptads from position 40 (Fig. 1A, Peptide ST).

Design of the SNRD Control Peptide-- A control peptide corresponding to the scrambled sequence of the selected SNAP-25 peptide was also synthesized. Randomized sequences were generated, their secondary structures were predicted using the SOPMA method, and the sequences with an alpha -helical content similar to the original sequence were run against the Prosite data base. A peptide with the same functional sites but without the heptad periodicity was synthesized (sequence shown under "Experimental Procedures"), and it was shown to be pharmacologically inactive. The SNRD peptide, at variance to SN, did not affect Ca2+-dependent release in chromaffin cells.

Secondary structure predictions using the SOPMA method (21, 22) indicate that all three peptides may form stable alpha -helices in the context of a whole protein structure. Predicted helicities for SN, SB, and ST peptides were 62, 96, and 86%, respectively, when considered integrated in the protein, in contrast to 42, 57, and 67% as isolated peptides. The behavior of the isolated peptides in an aqueous environment was predicted by using the AGADIR algorithm (23). This program uses statistical mechanics to consider short range interactions between residues at different pH and temperature. Given the size of our peptides, they are predicted to be unstructured (4% for SN, 3% for SB, and 2% for ST peptide, respectively) under aqueous conditions. Thus, considering both sets of data, we infer that these peptides can adopt alpha -helical structures only in the context of the intact protein and, therefore, that the presence of helicity-inducing conditions may be necessary to mimic the secondary structure of the peptides in the cytosol. TFE, a hydrophilic and hydrogen-bonding solvent, has been widely used to stabilize marginally stable alpha -helical structures in potentially alpha -helical peptides (48, 50-53). TFE is not limited to promoting helix formation, since it has also been shown to stabilize beta -turns and even beta -strands (54, 55). Notwithstanding, TFE-induced alpha -helical conformation in fragments of proteins known to be beta -sheet in the native context has been documented (56-63). Therefore, caution must be exercised in inferring structure from CD data of peptides in the presence of TFE, particularly with regard to the extent that it represents the native structure in the context of the intact protein from which the peptide sequences were selected.

Trimeric Coiled-coil Model

Theoretical Considerations-- A model of one of the trimeric conformers of the selected peptides forming a coiled-coil structure is shown in Fig. 1B. Given the helical wheel representation, residues at the a- and d-positions stabilize the structure by hydrophobic interchain interactions. According to this model, the synaptobrevin-2 residue Met45, which upon mutation inhibits endocytosis, would be located in the hydrophobic core, where such a change would be predictably disruptive. The mutations in syntaxin that reduce its binding to SNAP-25 would also be located in positions a and d (residues denoted with an asterisk in Fig. 1B). Interestingly, the cleavage sites for five of the seven BoNT serotypes (BoNT A, B, D, E, and F) are found in the model peptides, and all are in surface locations potentially accessible to the BoNT proteases.

Interchain interactions of e- and g-positions mediated by charged residues also contribute to the stability of a coiled-coil (64). There are 12 charged residues in positions e and g; accordingly, inter- or intrahelical ionic interactions could synergistically contribute to the stability of the coil (Fig. 1C). Polar residues implanted in the hydrophobic core are potentially disruptive, although strategic placement can facilitate correct oligomerization arrangements (65). In the model, the core contains only two charged residues: Arg198 (peptide ST) could establish an intramolecular salt bridge with either Glu194 or Glu201 (Fig. 1B), and Arg56 (peptide SB) would be at a suitable distance to interact with the glutamate residues in position g of the ST peptide and form an intermolecular linkage (Fig. 1B).

In the outer layer (positions b, c, and f), 14 negatively and 3 positively charged residues would be exposed. This arrangement of negative charges mostly in the surface is consistent with observations by Regazzi et al. (47) that substitutions of negatively charged residues of synaptobrevin-2 do not alter function (66) (Fig. 1B).

Circular Dichroism Results-- In aqueous media, all peptides (alone or in mixtures) were unstructured, and neither increasing peptide concentration nor changing pH, ionic strength, or divalent cation concentration increased the alpha -helical content. Typical single-stranded polypeptides generally do not form stable alpha -helices in aqueous solution and require the additional stabilization of less polar solvents (67, 68); therefore, we resorted to the use of the helix-promoting solvent TFE.

In the presence of increasing concentrations of TFE (Fig. 2, A-C), there was a significant increase in the alpha -helical content. The minimal concentration at which the peptides underwent a transition from mostly unstructured to partially structured was approximately 30%. At that concentration, the alpha -helical contents of the SNAP-25, synaptobrevin, and syntaxin peptides were 31, 44, and 32%, respectively. At the maximum concentration of TFE used (75%), the alpha -helical contents of the peptides were 59, 87, and 85%, respectively. TFE increases the alpha -helical content, while it disrupts tertiary and quaternary structures stabilized by hydrophobic interactions (69); therefore, it was imperative to use a concentration of TFE low enough to marginally stabilize the secondary structure of monomeric peptides while still allowing the expression of tertiary interactions. Notwithstanding the disrupting effects of TFE on the tertiary structure of oligomeric complexes, peptide-peptide interactions producing stable oligomers have been documented at concentrations of TFE as high as 50% (70). Interestingly, the TFE concentration used in our experiments (30%) has been reported to yield for numerous peptides secondary structures that compare favorably with those of the native systems (71-73).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   CD spectra of the synthetic peptides at different TFE concentrations. A, SN peptide; B, SB peptide; C, ST peptide. Spectra were recorded in 10 mM sodium phosphate, pH 7.4, 100 mM NaCl, in the presence of increasing concentrations of TFE. Peptide concentration was 30 µM. TFE concentrations used were 10, 20, 30 (*), 40, 50, 65, and 75%.

Equimolar ternary mixtures SN/SB/ST in aqueous solution showed no interaction between the non-alpha -helical peptides (not shown). In the presence of TFE, the spectrum of the SN/SB/ST mixture (Fig. 3E, solid line) was significantly different from a noninteracting spectrum (Fig. 3E, dashed line) calculated from the three individual CD spectra (Fig. 3A). The expected alpha -helicity from the calculated spectrum was 35%, whereas the alpha -helicity from the experimental spectrum was 46%; i.e. a 31% net increase over the predicted value. The ratios between the intensities of the bands at 222 and 208 nm were 0.76 for the calculated and 0.80 for the experimental spectrum, respectively. This larger Theta 222/Theta 208 ratio is consistent with an increase in coiling.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   CD spectra of binary and ternary mixtures of synthetic peptides SN, SB, and ST. Experimental (solid line) and calculated (dashed line) noninteracting spectra are shown for each mixture as well as recordings corresponding to the same peptide mixture after a 24-h incubation at 5 °C. A, individual spectra of SN, SB, and ST peptides used to determine the calculated noninteracting spectra; B, SN/SB mixture; C, SB/ST mixture; D, SN/ST mixture; E, SN/SB/ST ternary mixture; F, comparison between the spectrum of the ternary mixture after a 24-h incubation and the spectrum calculated from the summation of the binary spectra. Peptide concentration was 30 µM for each peptide. Spectra were recorded in 10 mM sodium phosphate, pH 7.4, 100 mM NaCl, with 30% TFE.

The 31% net increase in helicity observed in the experimental ternary mixture spectrum with respect to the prediction could arise from the occurrence of distinct binary complexes in the mixture. Equimolar binary mixtures SN/SB, SN/ST, and SB/ST in aqueous solution showed no interaction between the peptides (not shown). In the presence of 30% TFE, the SN and SB peptides did not interact in binary mixtures (Fig. 3B). The helicity of the experimental spectrum was identical to that predicted by the noninteracting calculated spectrum (36%). In contrast, spectra from binary mixtures SB/ST (Fig. 3C) and SN/ST (Fig. 3D) indicated that both pairs of peptides interact under these experimental conditions. In each case, the alpha -helical content calculated from the experimental spectra was ~15% greater than expected for a noninteracting mixture. Predicted helicities were 34 and 33%, respectively, for the SB/ST and SN/ST mixtures, whereas the experimental values were 39 and 38%, i.e. 15% higher than expected for noninteracting mixtures.

Increasingly higher peptide concentration in equimolar mixtures of the SN, SB, and ST peptides in the presence of 30% TFE (Fig. 4A) also results in an increase in helicity and therefore a stabilization of the complex. Increasing the individual peptide concentrations from 10 to 30 µM results in an increase in helicity from 46 to 54%. It is noticeable that the three spectra define a unique isodichroic point, consistent with the occurrence of a single specific complex. When equimolar ternary mixtures are exposed to higher concentrations of NaCl in the presence of 30% TFE (Fig. 4B), there is a remarkable increase in the helicity (from 55% at 0.1 M NaCl to 72% at 0.5 M and 81% at 1 M). This feature is consistent with hydrophobic peptide-peptide interactions as suggested by the model (Fig. 1B). The increased alpha -helical content with increasing ionic strength is in accordance with data for coiled-coil peptides and can be explained by the increased strength of the hydrophobic interactions as the polarity of the medium is increased (69).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   CD spectra of ternary mixtures of the SN, SB, and ST peptides as function of peptide concentration and ionic strength. A, CD spectra of equimolar mixtures of SN, SB, and ST peptides, at individual peptide concentrations of 10, 20, and 30 µM. Spectra were recorded in 10 mM sodium phosphate, pH 7.4, 100 mM NaCl, with 30% TFE; B, effect of increasingly higher concentrations of NaCl on the secondary structure of equimolar ternary mixtures of SN, SB, and ST peptides at individual peptide concentrations of 30 µM. Spectra were recorded in 10 mM sodium phosphate, pH 7.4, 30% TFE. NaCl concentrations used were 0.1, 0.5, and 1 M.

Whereas the spectra of all three peptides were independent of the peptide concentration in aqueous solution (Fig. 5, A-C), in the presence of 30% TFE the increase in peptide concentration resulted in a concomitant increase in the alpha -helical content, as indicated by the increase in negative ellipticity at 222 nm (Fig. 5, D-F). Helicity increased from 30 to 53% for SN, from 41 to 49% for SB, and from 35 to 51% for ST. This is consistent with the fact that peptides with alpha -helical structures that are dependent on dimerization or oligomerization show an augmentation of alpha -helical content as the peptide concentration is increased (74). This presumably arises because the equilibrium between monomeric peptide (in the form of random coil) and coiled-coil dimer is shifted toward the formation of the coiled-coil dimer, which increases the alpha -helical content of the peptide (65).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   CD spectra of the synthetic peptides at increasingly higher concentrations in the absence or presence of TFE. A, SN peptide; B, SB peptide; and C, ST peptide in aqueous solution. D, SN peptide; E, SB peptide; and F, ST peptide in 30% TFE. Peptide concentrations were 30, 60, and 90 µM, respectively. Spectra were recorded in 10 mM sodium phosphate, pH 7.4, 100 mM NaCl, with or without 30% TFE.

Higher peptide concentrations induced a moderate increase in the ratio between the peaks at 222 and 208 nm (Theta 222/Theta 208): from 0.68 to 0.78 for SN; from 0.75 to 0.77 for SB; and from 0.88 to 0.94 for ST. The ratio between the intensities of the bands at 222 and 208 nm may be regarded as a measure for the extent of coiling of alpha -helices around each other. The 222-nm CD band is mainly responsive to the alpha -helical content, whereas the band at 208 nm is sensitive to whether the alpha -helix is monomeric or is involved in tertiary contacts with other alpha -helices (75-77). Therefore, this is an additional criterion for the formation of stable coiled-coil structures. Each set of curves defined a unique isodichroic point, consistent with a single monomer-dimer equilibrium, which indicated that the oligomerization observed was sequence-specific and presumably stabilized by a concerted set of ion pairs in a defined spatial arrangement.

The ratio of the 222- to the 208-nm peak is an operational index to detect the presence of pure coiled-coils. For peptides stabilized at low TFE concentrations, an equilibrium between monomeric and multimeric states is anticipated, resulting in a profile intermediate between a pure coiled-coil and a predominantly monomeric situation. Given that the peptides exhibit a relatively low alpha -helical content and that there is a substantial fraction of peptide in monomeric form, the formation of homomeric or heteromeric arrays arising from interhelical interactions would result in an alpha -helical content of the mixtures larger than that expected from a spectrum calculated from the individual spectra (Fig. 3A).

To address the question of whether the increase in alpha -helicity observed in the ternary mixture could be accounted for by mere binary interactions between the SN, SB, and ST peptides, the calculated spectrum predicted from the sum of SN/ST and SB/ST interactions was calculated (Fig. 3F, dashed line). The experimental spectrum obtained from the ternary mixture (Fig. 3F, solid line) showed an alpha -helical content (46%) considerably higher than expected from a mixture of dimers (38%), suggesting the presence of ternary or higher order interactions.

The specificity of the interactions observed in binary mixtures was tested using mixtures of the SN, SB, and ST peptides with the SNRD control peptide (Fig. 6). The SNRD peptide was unstructured in aqueous solution, and in the presence of 30% TFE its alpha -helical content was similar to that of the SN peptide (spectrum not shown). Equimolar mixtures of SNRD and SN (SN/SNRD) showed no difference between the spectrum calculated for a noninteracting mixture and the experimental spectrum (Fig. 6A). Similarly, spectra obtained from SB/SNRD and ST/SNRD binary mixtures showed no difference with respect to the calculated noninteracting spectra (Fig. 6, B and C). The slight differences observed in the figure are not statistically significant as assessed using a Student's t test on the nonfiltered spectra. In the case of mixtures assayed in the presence of 30% TFE, the situation is the same: there is no interaction between SN, SB, or ST and the control peptide (Fig. 6, D-F). This indicates that the interactions observed upon increasing peptide concentration or mixing with other peptides, either in binary or ternary mixtures, is sequence-specific.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   CD spectra of binary mixtures of synthetic peptides SN, SB, and ST and the control peptide SNRD. A, SN/SNRD mixture; B, SB/SNRD mixture; and C, ST/SNRD mixture in aqueous solution. D, SN/SNRD mixture; E, SB/SNRD; and F, SB/SNRD mixture in 30% TFE. Experimental (solid line) and calculated (dashed line) noninteracting spectra are shown for each binary mixture. Peptide concentration was 30 µM. Spectra were recorded in 10 mM sodium phosphate, pH 7.4, 100 mM NaCl, with or without 30% TFE.

Conclusion

Our study identifies a minimal entity that opens a new perspective for the study of the molecular interactions between SNAP-25, synaptobrevin, and syntaxin. Three distinct synthetic peptides patterned after the sequences of the putative coiled-coil-forming domains of the main components of the docking and fusion complex self-assemble into a complex that exhibits spectral characteristics consistent with a coiled-coil structure. A synthetic coiled-coil ternary complex provides a basis for further developments: 1) the ternary complex appears suitable for both crystallization and NMR spectroscopy that, in due turn, may yield a high resolution structure of the fusion core complex; 2) it represents a conceptual framework to assist in the design and test of new peptide inhibitors of neurotransmitter release; 3) it provides leads for the design of small molecule peptidomimetic drugs; and 4) it may be valuable to generate specific antibodies to block neurotransmitter release. Indeed, the synthetic peptides that, as shown here, participate in the assembly of the ternay complex in fact mimic the action of Clostridial neurotoxins (40, 43). Therefore, our findings may lead to the development of peptide-based agents that may be used as potential therapy in spastic neuromuscular disorders, substituting or complementing the current treatment with BoNTs.

    ACKNOWLEDGEMENTS

We thank Professor Murray Goodman and Dr. Joseph Taulane for the use of the Cary 61 CD spectrometer and Dr. Susan S. Taylor for the use of the AVIV 202 CD spectrometer.

    Note Added in Proof

After submission of this manuscript, two papers reported the structure of the SNARE complex as a parallel four-helix bundle determined by x-ray crystallography (Sutton R. B., Fasshauer, D., Jahn, R., and Brunger, A. T. (1998) Nature 395, 347-353) and by electron paramagnetic resonance spectroscopy (Poirier, M. A., Xiao, W., Macosko, J. C., Chan, C., Shin, Y.-K., and Bennett, M. K. (1998) Nat. Struct. Biol. 5, 765-769). The results of our study are consistent with the high resolution structure of the SNARE complex.

    FOOTNOTES

* This work was supported by U.S. Army Medical Research and Materiel Command Grants DAMD 17-93-C-3100 and DAMD 17-98-C-8040 (to M. M.) and a grant from the Dystonia Medical Research Foundation (to J. M. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Biology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0366. Tel./Fax: 619-534-0931; E-mail: montal{at}biomail.ucsd.edu.

The abbreviations used are: SNARE, SNAP receptor; v-SNARE, vesicle SNARE; t-SNARE, target SNARE; BoNT, botulinum neurotoxin; SNAP-25, synaptosomal associated protein of 25 kDa; TFE, trifluoroethanol; HPLC, high pressure liquid chromatography.
    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Calakos, N., Bennet, M. K., Peterson, K. E., and Scheller, R. H. (1994) Science 263, 1146-1149[Abstract/Free Full Text]
  2. Chapman, E. R., An, S., Barton, N., and Jahn, R. (1994) J. Biol. Chem. 269, 27427-27432[Abstract/Free Full Text]
  3. Hayashi, T., McMahon, H., Yamasaki, S., Binz, T., Hata, Y., Sudhof, T. C., and Niemann, H. (1994) EMBO J. 13, 5051-5061[Medline] [Order article via Infotrieve]
  4. Kee, Y., Lin, R. C., Hsu, S. C., and Scheller, R. H. (1995) Neuron 14, 991-998[CrossRef][Medline] [Order article via Infotrieve]
  5. Hayashi, T., Yamasaki, S., Nauenburg, S., Binz, T., and Niemann, H. (1995) EMBO J. 14, 2317-2325[Medline] [Order article via Infotrieve]
  6. Sudhof, T. C. (1995) Nature 375, 645-653[CrossRef][Medline] [Order article via Infotrieve]
  7. Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve]
  8. Sollner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993) Cell 75, 409-418[CrossRef][Medline] [Order article via Infotrieve]
  9. Rothman, J. E., and Sollner, T. (1997) Science 276, 1212-1213[Free Full Text]
  10. Weber, T., Zemeelman, B., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Sollner, T., and Rothman, J. E. (1998) Cell 92, 759-7772[CrossRef][Medline] [Order article via Infotrieve]
  11. Zhong, P., Chen, Y. A., Tam, D., Chung, D., Scheller, R. H., and Miljanich, G. P. (1997) Biochemistry 36, 4317-4326[CrossRef][Medline] [Order article via Infotrieve]
  12. Lin, R. C., and Scheller, R. H. (1997) Neuron 19, 1087-1094[CrossRef][Medline] [Order article via Infotrieve]
  13. Gerst, J. E. (1997) J. Biol. Chem. 272, 16591-16598[Abstract/Free Full Text]
  14. Fasshauer, D., Bruns, D., Shen, B., Jahn, R., and Brunger, A. T. (1997) J. Biol. Chem. 272, 4582-4590[Abstract/Free Full Text]
  15. Hanson, P. I., Roth, R., Morisaki, H., Jahn, R., and Heuser, J. E. (1997) Cell 90, 523-535[CrossRef][Medline] [Order article via Infotrieve]
  16. O'Shea, E. K., Lumb, K. J., and Kim, P. S. (1993) Curr. Biol. 3, 658-667[CrossRef][Medline] [Order article via Infotrieve]
  17. King, D. S., Fields, C. G., and Fields, G. B. (1990) Int. J. Pept. Protein Res. 36, 255-266[Medline] [Order article via Infotrieve]
  18. Lupas, A., Van Dyke, M., and Stock, J. (1991) Science 252, 1162-1164[CrossRef][Medline] [Order article via Infotrieve]
  19. Lupas, A. (1996) Methods Enzymol. 266, 513-525[Medline] [Order article via Infotrieve]
  20. Berger, B., Wilson, D. B., Wolf, E., Tonchev, T., Milla, M., and Kim, P. S. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 8259-8263[Abstract/Free Full Text]
  21. Geourjon, C., and Deleage, G. (1994) Protein Eng. 7, 157-164[Abstract/Free Full Text]
  22. Geourjon, C., and Deleage, G. (1995) Comp. Appl. Biosci. 11, 681-684[Abstract/Free Full Text]
  23. Munoz, V., and Serrano, L. (1997) Biopolymers 41, 495-509[CrossRef][Medline] [Order article via Infotrieve]
  24. Feng, Y., Melacini, G., Taulane, J. P., and Goodman, M. (1996) J. Am. Chem. Soc. 118, 10351-10358[CrossRef]
  25. Schmid, F. X. (1989) in Protein Structure: A Practical Approach (Creighton, T. E., ed), pp. 251-286, IRL Press, Oxford
  26. Chen, Y. H., Yang, J. T., and Chau, K. H. (1974) Biochemistry 13, 3350-3359[CrossRef][Medline] [Order article via Infotrieve]
  27. Andrade, M. A., Chacon, P., Merelo, J. J., and Moran, F. (1993) Protein Eng. 6, 383-390[Abstract/Free Full Text]
  28. Archer, B. T., III, Ozcelik, T., Jahn, R., Francke, U., and Sudhof, T. (1990) J. Biol. Chem. 265, 17267-17273[Abstract/Free Full Text]
  29. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Sudhof, T. C., Jahn, R., and Niemann, H. (1994) J. Biol. Chem. 269, 1617-1620[Abstract/Free Full Text]
  30. Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Sudhof, T. C., Niemann, H., and Jahn, R. (1993) Nature 365, 160-163[CrossRef][Medline] [Order article via Infotrieve]
  31. Foran, P., Lawrence, G. W., Shone, C. C., Foster, K. A., and Dolly, J. O. (1996) Biochemistry 35, 2630-2636[CrossRef][Medline] [Order article via Infotrieve]
  32. Schiavo, G., Santucci, A., DasGupta, B. R., Mehta, P. P., Jontes, J., Benfenati, F., Wilson, M. C., and Montecucco, C. (1993) FEBS Lett. 335, 99-103[CrossRef][Medline] [Order article via Infotrieve]
  33. Schiavo, G., Rosetto, O., Catsicas, S., Polverino de Laureto, P., DasGupta, B. R., Benfenati, F., and Montecucco, C. (1993) J. Biol. Chem. 268, 23784-23787[Abstract/Free Full Text]
  34. Schiavo, G., Shone, C. C., Bennet, M. K., Scheller, R. H., and Montecucco, C. (1995) J. Biol. Chem. 270, 10566-10570[Abstract/Free Full Text]
  35. Williamson, L. C., Halpern, J. L., Montecucco, C., Brown, J. E., and Neale, E. A. (1996) J. Biol. Chem. 271, 7694-7699[Abstract/Free Full Text]
  36. Yamasaki, S., Baumeister, A., Binz, T., Blasi, J., Link, E., Cornille, F., Roques, B., Fykse, E. M., Sudhof, T. C., Jahn, R., and Niemann, H. (1994) J. Biol. Chem. 269, 12764-12772[Abstract/Free Full Text]
  37. Yamasaki, S., Binz, T., Hayashi, T., Szabo, E., Yamasaki, N., Eklund, M., Jahn, R., and Niemann, H. (1994) Biochem. Biophys. Res. Commun. 200, 829-835[CrossRef][Medline] [Order article via Infotrieve]
  38. Cornille, F., Deloye, F., Fournie-Zaluski, M. C., Roques, B. P., and Poulain, B. (1995) J. Biol. Chem. 270, 16826-16832[Abstract/Free Full Text]
  39. Gutierrez, L. M., Canaves, J. M., Ferrer-Montiel, A. V., Reig, J. A., Montal, M., and Viniegra, S. (1995) FEBS Lett. 372, 39-43[CrossRef][Medline] [Order article via Infotrieve]
  40. Gutierrez, L. M., Viniegra, S., Rueda, J., Ferrer-Montiel, A. V., Canaves, J. M., and Montal, M. (1996) J. Biol. Chem. 272, 2634-2639[Abstract/Free Full Text]
  41. Hunt, J. M., Bommert, K., Charlton, M. P., Kistner, A., Haberman, E., Augustine, G. J., and Betz, H. (1994) Neuron 12, 1269-1279[CrossRef][Medline] [Order article via Infotrieve]
  42. Martin, F., Salinas, E., Vazquez, J., Soria, B., and Reig, J. A. (1996) Biochem. J. 320, 201-205
  43. Ferrer-Montiel, A. V., Gutierrez, L. M., Apland, J. P., Canaves, J. M., Gil, A., Viniegra, S., Adler, M., and Montal, M. (1998) FEBS Lett. 435, 84-88[CrossRef][Medline] [Order article via Infotrieve]
  44. Kee, Y., and Scheller, R. H. (1996) J. Neurosci. 16, 1975-1981[Abstract/Free Full Text]
  45. Grote, E., and Kelly, R. B. (1996) J. Cell Biol. 132, 537-547[Abstract/Free Full Text]
  46. Hao, J. C., Salem, N., Peng, X. R., Kelly, R. B., and Bennet, M. K. (1997) J. Neurosci. 17, 1596-1603[Abstract/Free Full Text]
  47. Regazzi, R., Sadoul, K., Meda, P., Kelly, R. B., Halban, P. A., and Wollheim, C. B. (1996) EMBO J. 15, 6951-6959[Medline] [Order article via Infotrieve]
  48. Hodges, R. S., Zhou, N. E., Kay, C. M., and Semchuk, P. D. (1990) Peptide Res. 3, 123-137
  49. Marmorstein, R., Carey, M., Ptashne, M., and Harrison, S. C. (1992) Nature 356, 408-414[CrossRef][Medline] [Order article via Infotrieve]
  50. Nelson, J. W., and Kallenbach, N. R. (1986) Proteins 1, 211-217[CrossRef][Medline] [Order article via Infotrieve]
  51. Nelson, J. W., and Kallenbach, N. R. (1990) Biochemistry 28, 5256-5261
  52. Dyson, H. J., Merutka, G., Waltho, J. P., Lerner, R. A., and Wright, P. E. (1992) J. Mol. Biol. 226, 795-818[CrossRef][Medline] [Order article via Infotrieve]
  53. Dyson, H. J., Sayre, J. R., Merutka, G., Shin, H. C., Lerner, R. A., and Wright, P. E. (1992) J. Mol. Biol. 226, 819-835[CrossRef][Medline] [Order article via Infotrieve]
  54. Blanco, J. F., and Serrano, L. (1995) Eur. J. Biochem. 230, 634-649[Medline] [Order article via Infotrieve]
  55. Narayanan, U., Keiderling, T. A., Bonora, G. M., and Toniolo, C. (1986) J. Am. Chem. Soc. 108, 2431-2437[CrossRef]
  56. Dong, A., Matsuura, J., Manning, M. C., and Carpenter, J. F. (1998) Arch. Biochem. Biophys. 355, 275-281[CrossRef][Medline] [Order article via Infotrieve]
  57. Arunkumar, A. I., Kumar, T. K. S., and Yu, C. (1997) Biochim. Biophys. Acta 1338, 69-76[CrossRef][Medline] [Order article via Infotrieve]
  58. Jayaraman, G., Kumar, T. K. S., Arunkumar, A. I., and Yu, C. (1996) Biochem. Biophys. Res. Commun. 222, 33-37[CrossRef][Medline] [Order article via Infotrieve]
  59. Luidens, M. K., Figge, J., Breese, K., and Vajda, S. (1996) Biopolymers 39, 367-376[CrossRef][Medline] [Order article via Infotrieve]
  60. Schonbrunner, N., Wey, J., Engels, J., Georg, H., and Kiefhaber, T. (1996) J. Mol. Biol. 260, 432-445[CrossRef][Medline] [Order article via Infotrieve]
  61. Hamada, D., and Goto, Y. (1997) J. Mol. Biol. 269, 479-487[CrossRef][Medline] [Order article via Infotrieve]
  62. Najbar, L. V., Craik, D. J., Wade, J. D., Salvatore, D., and McLeish, M. J. (1997) Biochemistry 36, 11525-11533[CrossRef][Medline] [Order article via Infotrieve]
  63. MacPhee, C. E., Perugini, M. A., Sawyer, W. H., and Howlett, G. J. (1997) FEBS Lett. 416, 265-268[CrossRef][Medline] [Order article via Infotrieve]
  64. Zhou, N. E., Kay, C. M., and Hodges, R. S. (1994) Protein Eng. 7, 1365-1372[Abstract/Free Full Text]
  65. Adamson, J. G., Zhou, N. E., and Hodges, R. S. (1993) Curr. Opin. Biotechnol. 4, 428-437[CrossRef][Medline] [Order article via Infotrieve]
  66. Pellizzari, R., Rosetto, O., Lozzi, L., Giovedi, S., Johnson, E., Shone, C. C., and Montecucco, C. (1996) J. Biol. Chem. 271, 20353-20358[Abstract/Free Full Text]
  67. Bierzynski, A., Kim, P. S., and Baldwin, R. L. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2470-2474[Abstract/Free Full Text]
  68. Brown, J. E., and Klee, W. A. (1971) Biochemistry 10, 470-476[CrossRef][Medline] [Order article via Infotrieve]
  69. Lau, S. Y. M., Taneja, A. K., and Hodges, R. S. (1984) J. Biol. Chem. 259, 13253-13261[Abstract/Free Full Text]
  70. Vinogradov, A. A., Mari, F., Humphreys, R. E., and Wright, G. E. (1996) Int. J. Pept. Protein Res. 47, 467-476[Medline] [Order article via Infotrieve]
  71. Munoz, V., Serrano, L., Jimenez, M. A., and Rico, M. (1995) J. Mol. Biol. 247, 648-669[CrossRef][Medline] [Order article via Infotrieve]
  72. Blanco, F. J., Ortiz, A. R., and Serrano, L. (1997) Folding Design 2, 123-133[CrossRef][Medline] [Order article via Infotrieve]
  73. Ramirez-Alvarado, M., Serrano, L., and Blanco, F. J. (1997) Protein Sci. 6, 162-174[Abstract]
  74. Zhou, N. E., Kay, C. M., and Hodges, R. S. (1992) J. Biol. Chem. 267, 2664-2670[Abstract/Free Full Text]
  75. Zhou, N. E., Zhu, B. Y., Kay, C. M., and Hodges, R. S. (1992) Biopolymers 32, 419-426[CrossRef][Medline] [Order article via Infotrieve]
  76. Cooper, T. M., and Woody, R. W. (1990) Biopolymers 30, 657-676[CrossRef][Medline] [Order article via Infotrieve]
  77. Greenfield, N. J., and Hitchcock-DeGregori, S. E. (1995) Biochemistry 34, 16797-16805[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
M. Kreiner, Z. Li, J. Beattie, S.M. Kelly, H.J. Mardon, and C.F. van der Walle
Self-assembling multimeric integrin {alpha}5{beta}1 ligands for cell attachment and spreading
Protein Eng. Des. Sel., September 1, 2008; 21(9): 553 - 560.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Paumet, V. Rahimian, and J. E. Rothman
The specificity of SNARE-dependent fusion is encoded in the SNARE motif
PNAS, March 9, 2004; 101(10): 3376 - 3380.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
F. Paumet, B. Brugger, F. Parlati, J. A. McNew, T. H. Sollner, and J. E. Rothman
A t-SNARE of the endocytic pathway must be activated for fusion
J. Cell Biol., December 10, 2001; 155(6): 961 - 968.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Paumet, J. Le Mao, S. Martin, T. Galli, B. David, U. Blank, and M. Roa
Soluble NSF Attachment Protein Receptors (SNAREs) in RBL-2H3 Mast Cells: Functional Role of Syntaxin 4 in Exocytosis and Identification of a Vesicle-